Cargando…
Improving Lithium Therapeutics by Crystal Engineering of Novel Ionic Cocrystals
[Image: see text] Current United States Food and Drug Administration (FDA)-approved lithium salts are plagued with a narrow therapeutic window. Recent attempts to find alternative drugs have identified new chemical entities, but lithium’s polypharmacological mechanisms for treating neuropsychiatric...
Autores principales: | Smith, Adam J., Kim, Seol-Hee, Duggirala, Naga K., Jin, Jingji, Wojtas, Lukasz, Ehrhart, Jared, Giunta, Brian, Tan, Jun, Zaworotko, Michael J., Shytle, R. Douglas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical
Society
2013
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3850245/ https://www.ncbi.nlm.nih.gov/pubmed/24191685 http://dx.doi.org/10.1021/mp400571a |
Ejemplares similares
-
Crystal Engineering of Ionic Cocrystals Sustained by Azolium···Azole Heterosynthons
por: Rahmani, Maryam, et al.
Publicado: (2022) -
Crystal Engineering of Ionic Cocrystals Sustained
by the Phenol–Phenolate Supramolecular Heterosynthon
por: Jin, Shasha, et al.
Publicado: (2022) -
Crystal Engineering of Green Tea Epigallocatechin-3-gallate
(EGCg) Cocrystals and Pharmacokinetic Modulation in Rats
por: Smith, Adam J., et al.
Publicado: (2013) -
Polymorphism in Ionic Cocrystals Comprising Lithium
Salts and l-Proline
por: Sanii, Rana, et al.
Publicado: (2022) -
Crystal engineering of ionic cocrystals comprising Na/K salts of hesperetin with hesperetin molecules and solubility modulation
por: Jin, Shasha, et al.
Publicado: (2023)